Microbiome Diversity

HaemaLogiX doses KMCAR T‑cell in KOALA trial

Discover the KMCAR T-cell dose in the KOALA Phase I trial, a promising CAR‑T option for relapsed or refractory kappa‑restricted multiple myeloma patients.

By Samoyed · Aug 30, 2026